Our Strategy

At Celera, our mission has evolved from sequencing the human genome to understanding how human variation relates to the disease process, with the goal of becoming the leading provider of diagnostics for personalizing disease management.

To accomplish this goal, partnering has been one of our key strategies. Partners gain access to our expertise and capabilities in proteomic and genetic discovery, in vitro diagnostic (IVD) product development, global product registration, GMP manufacturing, and our GLP/CLIA laboratory services.

Our Business Development and Alliance Management group is actively seeking to collaborate in areas that include diagnostics, pharmacogenomics and therapeutics.

Celera brings the considerable breadth of its resources to its partnerships as appropriate, and is open to a variety of collaboration structures.